Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease

Digestive Diseases and Sciences

Volumn 53, Issue 9, 2008, Pages 2495-2506

  Feighery, Linda M ^a   Smith, Philip ^b   O'Mahony, Liam ^c   Fallon, Padraic G ^b   Brayden, David J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Apparent permeability coefficient; Dextran sodium sulphate; IL 10 gene deficient mice (IL 10 ); Inflammatory bowel disease (IBD); Lactobacillus probiotics; Mannitol fluxes; Transepithelial electrical resistance

Indexed keywords

PROBIOTIC AGENT; UCC 118;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; ENTERITIS; FECES ANALYSIS; FEMALE; IMMUNE RESPONSE; IN VITRO STUDY; INTESTINE FUNCTION; INTESTINE MUCOSA PERMEABILITY; LACTOBACILLUS SALIVARIUS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 50249143507     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-007-0157-y     Document Type: Article

References (45)

1. B Sheil F Shanahan L O'Mahony 2007 Probiotic effects on inflammatory bowel disease J Nutr 137 819S 824S
2. Rolhion N, Darfeuille-Michaud A (2007) Adherent-invasive Escherichia coli in inflammatory bowel disease. Inflamm Bowel Dis May 2 [Epub ahead of print]
3. JG Bartlett 2007 Clostridium difficile: old and new observations J Clin Gastroenterol 41 Suppl 1 S24 S29
4. M Mylonaki NB Rayment DS Rampton BN Hudspith J Brostoff 2005 Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease Inflamm Bowel Dis 11 481 487
5. MH Giaffer CD Holdsworth BI Duerden 1991 The assessment of faecal flora in patients with inflammatory bowel disease by a simplified bacteriological technique J Med Microbiol 35 238 243
6. RK Sellon S Tonkonogy M Schultz LA Dieleman W Grenther E Balish DM Rennick RB Sartor 1998 Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice Infect Immun 66 5224 5231
7. L O'Mahony J McCarthy P Kelly G Hurley F Luo K Chen GC O'Sullivan B Kiely JK Collins F Shanahan EM Quigley 2005 Lactobacillus and Bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles Gastroenterology 128 541 551
8. PJ Whorwell L Altringer J Morel Y Bond D Charbonneau L O'Mahony B Kiely F Shanahan EM Quigley 2006 Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome Am J Gastroenterol 101 1581 1590
9. K Kajander K Hatakka T Poussa M Farkkila R Korpela 2005 A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention Aliment Pharmacol Ther 22 387 394
10. VE Rolfe PJ Fortun CJ Hawkey F Bath-Hextall 2006 Probiotics for maintenance of remission in Crohn's disease Cochrane Database Syst Rev 4 CD004826
11. S Macfarlane E Furrie A Kennedy JH Cummings GT Macfarlane 2005 Mucosal bacteria in ulcerative colitis Br J Nutr 93 Suppl 1 S67 S72
12. P Gionchetti F Rizzello M Campieri 2002 Probiotics in gastroenterology Curr Opin Gastroenterol 18 235 239
13. KL Madsen JS Doyle LD Jewel MM Tavernini RN Fedorak 1999 Lactobacillus species prevents colitis in interleukin 10 gene-deficient mice Gastroenterology 116 1107 1114
14. L O'Mahony M Feeney S O'Halloran L Murphy B Kiely J Fitzgibbon G Lee G O'Sullivan F Shanahan JK Collins 2001 Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice Aliment Pharmacol Ther 15 1219 1225
15. J McCarthy L O'Mahony L O'Callaghan B Sheil EE Vaughan N Fitzsimons J Fitzgibbon GC O'Sullivan B Kiely JK Collins F Shanahan 2003 Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance Gut 52 975 980
16. C Di Giacinto M Marinaro M Sanchez W Strober M Boirivant 2005 Probiotics ameliorate recurrent Th1-mediated murine colitis by inducing IL-10 and IL-10-dependent TGF-beta-bearing regulatory cells J Immunol 174 3237 3246
17. M Llopis M Antolin F Guarner A Salas JR Malagelada 2005 Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid Gut 54 955 999
18. F Lamine H Eutamene J Fioramonti L Bueno V Theodorou 2004 Colonic responses to Lactobacillus farciminis treatment in trinitrobenzene sulphonic acid-induced colitis in rats Scand J Gastroenterol 39 1250 1258
19. L Peran D Camuesco M Comalada A Nieto A Concha MP Diaz-Ropero M Olivares J Xaus A Zarzuelo J Galvez 2005 Preventative effects of a probiotic, Lactobacillus salivarius ssp. salivarius, in the TNBS model of rat colitis World J Gastroenterol 11 5185 5192
20. L Peran S Sierra M Comalada F Lara-Villoslada E Bailon A Nieto A Concha M Olivares A Zarzuelo J Xaus J Galvez 2007 A comparative study of the preventative effects exerted by two probiotics, Lactobacillus reuteri and Lactobacillus fermentum, in the trinitrobenzenesulfonic acid model of rat colitis Br J Nutr 97 96 103
21. MV Herias JF Koninkx JG Vos JH Huis in't Veld JE van Dijk 2005 Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice Int J Food Microbiol 103 143 155
22. C Dunne L O'Mahony L Murphy G Thornton D Morrissey S O'Halloran M Feeney S Flynn G Fitzgerald C Daly B Kiely GC O'Sullivan F Shanahan JK Collins 2001 In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings Am J Clin Nutr 73 Suppl 2 386S 392S
23. Corr SC, Li Y, Riedel CU, O'Toole PW, Hill C, Gahan CG (2007) Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Natl Acad Sci USA. 104:7617-7721. Epub 2007 Apr 24
24. GR May LR Sutherland JB Meddings 2003 Is small intestinal permeability really increased in relatives of patients with Crohn's disease? Gastroenterology 104 1627 1632
25. R D'Inca V Di Leo G Corrao D Martines A D'Odorico C Mestriner C Venturi G Longo GC Sturniolo 1999 Intestinal permeability test as a predictor of clinical course in Crohn's disease Am J Gastroenterol 94 2956 2960
26. JR Turner 2006 Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application Am J Pathol 169 1901 1909
27. DS Clark 1967 Comparison of pour and surface plate methods for determination of bacterial counts Can J Microbiol 13 1409 1412
28. R Kuhn J Lohler D Rennick K Rajewsky W Muller 1993 Interleukin-10- deficient mice develop chronic enterocolitis Cell 75 263 274
29. S Melgar A Karlsson E Michaelsson 2005 Acute colitis induced by dextran sulfate sodium progresses to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation Am J Physiol Gastrointest Liver Physiol 288 G1328 G1338
30. P Smith NE Mangan CM Walsh RE Fallon AN McKenzie N van Rooijen PG Fallon 2007 Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism J Immunol 178 4557 4566
31. HS Cooper SN Murthy RS Shah DJ Sedergran 1993 Clinicopathologic study of dextran sulfate sodium experimental murine colitis Lab Invest 69 238 249
32. AW Cuthbert 2003 Benzoquinolines and chloride secretion in murine colonic epithelium Br J Pharmacol 138 1528 1534
33. J Soni AW Baird LM O'Brien M McElroy JJ Callanan HF Bassett D Campion DJ Brayden 2006 Rat, ovine and bovine Peyer's patches mounted in horizontal diffusion chambers display sampling function J Control Release 115 68 77
34. P Artursson 1990 Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J Pharm Sci 79 476 482
35. NE Mangan N van Rooijen AN McKenzie PG Fallon 2006 Helminth-modified pulmonary immune response protects mice from allergen-induced airway hyperresponsiveness J Immunol 176 138 147
36. DR Mack S Michail S Wei L McDougall MA Hollingsworth 1999 Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression Am J Physiol 276 G941 G950
37. E Isolauri H Majamaa T Arvola I Rantala E Virtanen H Arvilommi 1993 Lactobacillus casei strain GG reverses increased intestinal permeability induced by cow milk in suckling rats Gastroenterology 105 1643 1650
38. S Matsumoto T Hara T Hori K Mitsuyama M Nagaoka N Tomiyasu A Suzuki M Sata 2005 Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells Clin Exp Immunol 140 417 426
39. E Gaudier C Michel JP Segain C Cherbut C Hoebler 2005 The VSL #3 probiotic mixture modifies microflora but does not heal chronic dextran-sodium sulfate-induced colitis or reinforce the mucus barrier in mice J Nutr 135 2753 2761
40. D Rachmilewitz K Katakura F Karmeli T Hayashi C Reinus B Rudensky S Akira K Takeda J Lee K Takabayashi E Raz 2004 Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis Gastroenterology 126 520 528
41. B Sheil J MacSharry L O'Callaghan A O'Riordan A Waters J Morgan JK Collins L O'Mahony F Shanahan 2006 Role of interleukin (IL-10) in probiotic-mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice Clin Exp Immunol 144 273 280
42. KL Madsen RN Fedorak MM Tavernini JS Doyle 2002 Normal breast milk limits the development of colitis in IL-10-deficient mice Inflamm Bowel Dis 8 390 398
43. A Kilara D Panyam 2003 Peptides from milk proteins and their properties Crit Rev Food Sci Nutr 43 607 633
44. A Garcia-Lafuente M Antolin F Guarner E Crespo JR Malagelada 2001 Modulation of colonic barrier function by the composition of the commensal flora in the rat Gut 48 503 507
45. FR Byrne JL Viney 2006 Mouse models of inflammatory bowel disease Curr Opin Drug Discov Devel 9 207 217